Maintaining immunological tolerance with Foxp3

von Boehmer H, isielow P . Self-nonself discrimination by T cells. Science 1990; 248:1369–1373.

Oettinger MA, Schatz DG, Gorka C, Baltimore D . RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990; 248:1517–1523.

Rocha B, von Boehmer H . Peripheral selection of the T cell repertoire. Science 1991; 251:1225–1228.

Kisielow P, Teh HS, Bluthmann H, von Boehmer H . Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 1988; 335:730–733.

Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395–1401.

Goldrath AW, Bevan MJ . Selecting and maintaining a diverse T-cell repertoire. Nature 1999; 402:255–262.

Goverman J, Woods A, Larson L, et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993; 72:551–560.

Lassmann H, Bruck W, Lucchinetti CF . The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007; 17:210–218.

Tabira T, Sakai K . Demyelination induced by T cell lines and clones specific for myelin basic protein in mice. Lab Invest 1987; 56:518–525.

Jiang H, Zhang SI, Pernis B . Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992; 256:1213–1215.

Koh DR, Fung-Leung WP, Ho A, et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8−/− mice. Science 1992; 256:1210–1213.

Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S . High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994; 78:399–408.

Traugott U . Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J Neuroimmunol 1987; 16:283–302.

Todd JA, Acha-Orbea H, Bell JI, et al. A molecular basis for MHC class II—associated autoimmunity. Science 1988; 240:1003–1009.

Ota K, Matsui M, Milford EL, et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346:183–187.

Abbas AK, Murphy KM, Sher A . Functional diversity of helper T lymphocytes. Nature 1996; 383:787–793.

Bettelli E, Oukka M, Kuchroo VK . T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8:345–350.

Mosmann TR, Coffman RL . TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145–173.

Khoury SJ, Hancock WW, Weiner HL . Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355–1364.

Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE . Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989; 124:132–143.

Bettelli E, Sullivan B, Szabo SJ, et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004; 200:79–87.

Chitnis T, Najafian N, Benou C, et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001; 108:739–747.

Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235–238.

Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133–1141.

Nardelli DT, Burchill MA, England DM, et al. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immunol 2004; 11:1075–1084.

Tran EH, Prince EN, Owens T . IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 2000; 164:2759–2768.

Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA . IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996; 157:3223–3227.

Hofstetter HH, Ibrahim SM, Koczan D, et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005; 237:123–130.

Matusevicius D, Kivisakk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999; 5:101–104.

Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13:423–431.

Fritz RB, Chou CH, McFarlin DE . Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol 1983; 130:191–194.

Kumar V, Sercarz EE . The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med 1993; 178:909–916.

Fowell D, Mason D . Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627–636.

Gershon RK, Kondo K . Infectious immunological tolerance. Immunology 1971; 21:903–914.

Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL . Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265:1237–1240.

Sakaguchi S . Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101:455–458.

Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T . Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985; 161:72–87.

Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151–1164.

Tang Q, Boden EK, Henriksen KJ, et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34:2996–3005.

Zwar TD, van Driel IR, Gleeson PA . Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells. Immunol Cell Biol 2006; 84:487–501.

Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S . Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3:135–142.

Stephens GL, McHugh RS, Whitters MJ, et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004; 173:5008–5020.

Shevach EM, Stephens GL . The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006; 6:613–618.

Kuniyasu Y, Takahashi T, Itoh M, et al. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 2000; 12:1145–1155.

Fontenot JD, Gavin MA, Rudensky AY . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330–336.

Godfrey VL, Wilkinson JE, Russell LB . X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991; 138:1379–1387.

Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB . Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA 1991; 88:5528–5532.

Blair PJ, Bultman SJ, Haas JC, et al. CD4+CD8− T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153:3764–3774.

Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68–73.

Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20–21.

Fontenot JD, Rudensky AY . A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6:331–337.

Tommasini A, Ferrari S, Moratto D, et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin Exp Immunol 2002; 130:127–130.

Khattri R, Cox T, Yasayko SA, Ramsdell F . An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337–342.

Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–1061.

Ono M, Shimizu J, Miyachi Y, Sakaguchi S . Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25− regulatory T cells. J Immunol 2006; 176:4748–4756.

Stephens LA, Mason D . CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25− subpopulations. J Immunol 2000; 165:3105–3110.

Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C . Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10:371–378.

Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162:5317–5326.

Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK . Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198:249–258.

Jordan MS, Boesteanu A, Reed AJ, et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2:301–306.

Apostolou I, Sarukhan A, Klein L, von Boehmer H . Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3:756–763.

Schmidt-Supprian M, Tian J, Grant EP, et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci USA 2004; 101:4566–4571.

Schmidt-Supprian M, Courtois G, Tian J, et al. Mature T cells depend on signaling through the IKK complex. Immunity 2003; 19:377–389.

Koonpaew S, Shen S, Flowers L, Zhang W . LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J Exp Med 2006; 203:119–129.

Zhang W, Sommers CL, Burshtyn DN, et al. Essential role of LAT in T cell development. Immunity 1999; 10:323–332.

Liston A, Rudensky AY . Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol 2007; 19:176–185.

Viret C, Janeway CA Jr . Self-specific MHC class II-restricted CD4−CD8− T cells that escape deletion and lack regulatory activity. J Immunol 2003; 170:201–209.

Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8–27.

Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12:431–440.

Zheng Y, Josefowicz SZ, Kas A, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445:936–940.

Marson A, Kretschmer K, Frampton GM, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007; 445:931–935.

Lin W, Haribhai D, Relland LM, et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007; 8:359–368.

Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329–341.

Tai X, Cowan M, Feigenbaum L, Singer A . CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6:152–162.

Fontenot JD, Dooley JL, Farr AG, Rudensky AY . Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 202:901–906.

Suzuki H, Kundig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268:1472–1476.

Kramer S, Schimpl A, Hunig T . Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995; 182:1769–1776.

Horak I, Lohler J, Ma A, Smith KA . Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 1995; 148:35–44.

Malek TR, Yu A, Vincek V, Scibelli P, Kong L . CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167–178.

Klebb G, Autenrieth IB, Haber H, et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 1996; 81:282–286.

Almeida AR, Legrand N, Papiernik M, Freitas AA . Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169:4850–4860.

Setoguchi R, Hori S, Takahashi T, Sakaguchi S . Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201:723–735.

Thornton AM, Donovan EE, Piccirillo CA, Shevach EM . Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004; 172:6519–6523.

Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ . Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 2002; 196:851–857.

Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ . CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 2004; 173:7259–7268.

Maloy KJ, Powrie F . Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol 2005; 6:1071–1072.

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY . A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:1142–1151.

Yates J, Rovis F, Mitchell P, et al. The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol 2007; 19:785–799.

Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF . Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001; 276:37672–37679.

Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006; 126:375–387.

Rao A, Luo C, Hogan PG . Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15:707–747.

Hogan PG, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003; 17:2205–2232.

Crabtree GR, Olson EN . NFAT signaling: choreographing the social lives of cells. Cell 2002; 109(Suppl):S67–S79.

Macian F, Garcia-Cozar F, Im SH, et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002; 109:719–731.

Heissmeyer V, Macian F, Im SH, et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 2004; 5:255–265.

Wang B, Lin D, Li C, Tucker P . Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 2003; 278:24259–24268.

Bettelli E, Dastrange M, Oukka M . Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005; 102:5138–5143.

Shevach EM . CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389–400.

von Boehmer H . Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6:338–344.

Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA . CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 2003; 100:10878–10883.

Nakamura K, Kitani A, Strober W . Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194:629–644.

Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303–310.

Paust S, Lu L, McCarty N, Cantor H . Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004; 101:10398–10403.

Grossman WJ, Verbsky JW, Barchet W, et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21:589–601.

Klein L, Khazaie K, von Boehmer H . In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003; 100:8886–8891.

Jordan MS, Riley MP, von Boehmer H, Caton AJ . Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol 2000; 30:136–144.

Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F . An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995–1004.

Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, et al. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166:3008–3018.

Suri-Payer E, Cantor H . Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun 2001; 16:115–123.

Van Parijs L, Abbas AK . Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280:243–248.

Malek TR, Bayer AL . Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4:665–674.

Barthlott T, Kassiotis G, Stockinger B . T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003; 197:451–460.

von Boehmer H . Dynamics of suppressor T cells: in vivo veritas. J Exp Med 2003; 198:845–849.

Shevach EM . From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006; 25:195–201.

Fantini MC, Becker C, Monteleone G, et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149–5153.

Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875–1886.

Apostolou I, von Boehmer H . In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004; 199:1401–1408.

O'Garra A, Vieira P . Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10:801–805.

Carrier Y, Yuan J, Kuchroo VK, Weiner HL . Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007; 178:179–185.